Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:37:19 UTC 2023
by
admin
on
Sat Dec 16 16:37:19 UTC 2023
|
| Protein Type | CYTOKINE |
| Protein Sub Type | INTERFERONS |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
H9CK7SS0T6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
H9CK7SS0T6
Created by
admin on Sat Dec 16 16:37:19 UTC 2023 , Edited by admin on Sat Dec 16 16:37:19 UTC 2023
|
PRIMARY | |||
|
C97503
Created by
admin on Sat Dec 16 16:37:19 UTC 2023 , Edited by admin on Sat Dec 16 16:37:19 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_29 | 1_139 |
| 1_1 | 1_99 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Nova exhibited a higher binding affinity for IFN receptor 2 (IFNR2) than rhIFN-α2b, which is one of the
possible reasons accounting for its stronger actions against tumor cells compared with rhIFN-α2b.
AGONIST
Kd
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
|
|||